Found: 6
Select item for more details and to access through your institution.
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29719-1
- By:
- Publication type:
- Article
Patient demographic and psychosocial characteristics associated with 30‐day recall of self‐reported lower urinary tract symptoms.
- Published in:
- Neurourology & Urodynamics, 2020, v. 39, n. 7, p. 1939, doi. 10.1002/nau.24461
- By:
- Publication type:
- Article
A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index‐29 (LURN SI‐29) questionnaire.
- Published in:
- Neurourology & Urodynamics, 2019, v. 38, n. 6, p. 1751, doi. 10.1002/nau.24067
- By:
- Publication type:
- Article
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
- Published in:
- BJU International, 2024, v. 134, n. 3, p. 484, doi. 10.1111/bju.16432
- By:
- Publication type:
- Article
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273782
- By:
- Publication type:
- Article
Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study.
- Published in:
- BMC Urology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12894-024-01500-0
- By:
- Publication type:
- Article